Nicole LaBrosse, SVP, CFO: Halozyme Therapeutics HALO Sell · Filed 23/02/21

Trade details

Type: Insider sale
Amount: $124,381.5
Shares · price: 2,525 sh · $49.26 a share
Held after: 9,066 sh
Stock: Halozyme Therapeutics HALO
Person: Nicole LaBrosseSVP, CFO
Trade date: 23/02/16
Filed: 23/02/21
Days to filing: 5 days

Sold 21.8% of holdings

Share of holding sold: 21.8%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/17~23/03/18

Nicole LaBrosse's recent trades

Nicole LaBrosseSVP, CFO
Planned saleHalozyme Therapeutics
Planned sale
Halozyme Therapeutics
HALO
$986.6K
14,700 sh
$986.6K
Filed 05/15
Traded 05/15
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$148.9K
1,913 sh
$148.9K
Filed 25/09/23
Traded 25/09/22
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$24.7K
314 sh
$24.7K
Filed 25/09/23
Traded 25/09/22
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$1M
13,240 sh
$1M
Filed 25/09/11
Traded 25/09/10
Nicole LaBrosseSVP, CFO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$509K
6,760 sh
$509K
Filed 25/09/11
Traded 25/09/10

Nicole LaBrosse, CFO — sold $124.4K of Halozyme Therapeutics HALO · 21.8% of holdings | Whalegun